A 3 Arm Randomized Study on Health-related QoL of Elderly Patients With Advanced Soft Tissue Sarcoma

NCT04780464 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

14

Enrollment

NETWORK

Sponsor class

Stopped Withdrawal grant provider

Conditions

Advanced Soft-tissue Sarcoma

Interventions

DRUG: Doxorubicin
DRUG: Doxorubicin
DRUG: Cyclophosphamide Oral Product
DRUG: Prednisolone
DRUG: Prednisone

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC